万邦生化医药集团药品检出可见异物

Core Viewpoint - The National Medical Products Administration of China announced on January 6 that 28 batches of non-compliant drugs were identified, including Coenzyme Q10 injection produced by Jiangsu Wanbang Biopharmaceutical Co., Ltd., which failed to meet standards regarding appearance and visible impurities [1]. Group 1: Non-compliance Details - The Coenzyme Q10 injection produced by Jiangsu Wanbang Biopharmaceutical Co., Ltd. was found to be non-compliant due to issues related to its characteristics and the presence of visible impurities [1]. - The inspection was conducted by the Guangdong Provincial Drug Inspection Institute, which reported the findings [1]. Group 2: Definition of Non-compliance - The characteristics section typically includes the appearance, odor, taste, solubility, and physical constants, reflecting the quality attributes of the drug [2]. - Visible impurities refer to insoluble substances that can be observed under specified visual conditions in injections and ophthalmic solutions, with a particle size or length usually greater than 50 micrometers [2].